Literature DB >> 19576637

Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona.

Carmen Muñoz-Almagro1, Cristina Esteva, Maria Fernandez de Sevilla, Laura Selva, Amadeu Gene, Roman Pallares.   

Abstract

OBJECTIVE: To describe the epidemiology of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae serotype 19A.
METHODS: We studied all children and adolescents with IPD caused by serotype 19A who were admitted to a Children's Hospital in Barcelona (1997-2007). Serotyping, antibiotic susceptibility and clonal analysis were performed.
RESULTS: Comparing the pre-vaccine period (1997-2001) with the early vaccine period (2002-2004) and the late vaccine period (2005-2007) there was an increase of IPD caused by serotype 19A: 1 of 58 episodes (1.7%) vs. 8 of 54 episodes (14.8%) vs. 27 of 123 episodes (21.9%), respectively (P = 0.002). All S. pneumoniae serotype 19A isolated in the pre-vaccine and early vaccine periods (n = 9) were penicillin susceptible, while in the late vaccine period, 12 of 27 (44%) were penicillin nonsusceptible (P = 0.01). A clonal analysis revealed 15 different sequence types (STs) expressing serotype 19A. 10 of them were preexisting STs associated with serotype 19A including the multidrug-resistant ST320 and ST276.
CONCLUSION: There was an increase of IPD caused by S. pneumoniae serotype 19A which was mainly related with the emergence of preexisting clones several of them closely related with international multidrug-resistant clones. These results should be considered when selecting the new conjugate pneumococcal vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576637     DOI: 10.1016/j.jinf.2009.05.012

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  20 in total

1.  Clonal evolution leading to maintenance of antibiotic resistance rates among colonizing Pneumococci in the PCV7 era in Portugal.

Authors:  Alexandra S Simões; Liliana Pereira; Sónia Nunes; António Brito-Avô; Hermínia de Lencastre; Raquel Sá-Leão
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

2.  Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009).

Authors:  J M Marimón; M Alonso; D Rolo; C Ardanuy; J Liñares; E Pérez-Trallero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-08       Impact factor: 3.267

Review 3.  Prevention of Invasive Pneumococcal Disease: Problems Emerged After Some Years of the 13-Valent Pneumococcal Conjugate Vaccine Use.

Authors:  Nicola Principi; Giuseppe Di Cara; Ilaria Bizzarri; Chiara Isidori; Paola Borgia; Costanza Mignini; Marco Saponara; Alberto Argentiero; Susanna Esposito
Journal:  Curr Infect Dis Rep       Date:  2018-01-24       Impact factor: 3.725

4.  Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008.

Authors:  David Tarragó; Lorenzo Aguilar; Raquel García; María-José Gimenez; Juan-José Granizo; Asunción Fenoll
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

5.  Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR.

Authors:  L Selva; P Ciruela; C Esteva; M F de Sevilla; G Codina; S Hernandez; F Moraga; J J García-García; A Planes; F Coll; I Jordan; N Cardeñosa; J Batalla; L Salleras; A Dominguez; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

6.  PsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal type.

Authors:  Carmen Muñoz-Almagro; Laura Selva; Carlos J Sanchez; Cristina Esteva; Mariona F de Sevilla; Roman Pallares; Carlos J Orihuela
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

7.  Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.

Authors:  Juan Picazo; Jesus Ruiz-Contreras; Juan Casado-Flores; Sagrario Negreira; Maria-Jesus García-de-Miguel; Teresa Hernández-Sampelayo; Enrique Otheo; Cristina Méndez
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

8.  Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media.

Authors:  Vishakha Sabharwal; Marisol Figueira; Stephen I Pelton; Melinda M Pettigrew
Journal:  Microbes Infect       Date:  2012-03-03       Impact factor: 2.700

9.  Clonal spread of levofloxacin-resistant streptococcus pneumoniae invasive isolates in Madrid, Spain, 2007 to 2009.

Authors:  Iciar Rodríguez-Avial; Belén Ramos; Esther Ríos; Emilia Cercenado; María Ordobás; Juan Carlos Sanz
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

10.  Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system.

Authors:  O Hurmic; N Grall; M Al Nakib; C Poyart; S Grondin; M-C Ploy; E Varon; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-15       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.